4 COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a
본 발명은 개체에게서 난소암을 평가하는 HE/HE4a 마커들의 용도를 포함한다. 난소암들의 진단, 등급 결정 및 단계 결정하고, 난소암으로 진단되었던 개체의 예후 및 치료 유효도를 결정하기 위해 HE/HE4a 마커를 사용하는 조성물들 및 방법들도 역시 포함된다. The invention includes the use of the HE/HE4a markers to assess ovarian cancer in a subject. Included also are compositions and methods of using HE/HE4a...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HELLSTROM INGEGERD ROIJER EVA RAYCRAFT JOHN HELLSTROM KARL ERIK FERMER CHRISTIAN |
| description | 본 발명은 개체에게서 난소암을 평가하는 HE/HE4a 마커들의 용도를 포함한다. 난소암들의 진단, 등급 결정 및 단계 결정하고, 난소암으로 진단되었던 개체의 예후 및 치료 유효도를 결정하기 위해 HE/HE4a 마커를 사용하는 조성물들 및 방법들도 역시 포함된다.
The invention includes the use of the HE/HE4a markers to assess ovarian cancer in a subject. Included also are compositions and methods of using HE/HE4a marker for diagnosis, grading and staging of ovarian cancers, determining prognosis and treatment effectiveness of a subject who has been diagnosed with ovarian cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20180014239A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20180014239A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20180014239A3</originalsourceid><addsrcrecordid>eNrjZLA2UXD29w3wD_YM8fT3C1Zw9HNR8HUN8fB3CVbwd1MIDXZVcPMPUnBxDXEN8vX0cwSpAkl4uJok8jCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSSeO8gIwNDCwMDQxMjY0tHY-JUAQBZOinP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>4 COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a</title><source>esp@cenet</source><creator>HELLSTROM INGEGERD ; ROIJER EVA ; RAYCRAFT JOHN ; HELLSTROM KARL ERIK ; FERMER CHRISTIAN</creator><creatorcontrib>HELLSTROM INGEGERD ; ROIJER EVA ; RAYCRAFT JOHN ; HELLSTROM KARL ERIK ; FERMER CHRISTIAN</creatorcontrib><description>본 발명은 개체에게서 난소암을 평가하는 HE/HE4a 마커들의 용도를 포함한다. 난소암들의 진단, 등급 결정 및 단계 결정하고, 난소암으로 진단되었던 개체의 예후 및 치료 유효도를 결정하기 위해 HE/HE4a 마커를 사용하는 조성물들 및 방법들도 역시 포함된다.
The invention includes the use of the HE/HE4a markers to assess ovarian cancer in a subject. Included also are compositions and methods of using HE/HE4a marker for diagnosis, grading and staging of ovarian cancers, determining prognosis and treatment effectiveness of a subject who has been diagnosed with ovarian cancer.</description><language>eng ; kor</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180207&DB=EPODOC&CC=KR&NR=20180014239A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180207&DB=EPODOC&CC=KR&NR=20180014239A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HELLSTROM INGEGERD</creatorcontrib><creatorcontrib>ROIJER EVA</creatorcontrib><creatorcontrib>RAYCRAFT JOHN</creatorcontrib><creatorcontrib>HELLSTROM KARL ERIK</creatorcontrib><creatorcontrib>FERMER CHRISTIAN</creatorcontrib><title>4 COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a</title><description>본 발명은 개체에게서 난소암을 평가하는 HE/HE4a 마커들의 용도를 포함한다. 난소암들의 진단, 등급 결정 및 단계 결정하고, 난소암으로 진단되었던 개체의 예후 및 치료 유효도를 결정하기 위해 HE/HE4a 마커를 사용하는 조성물들 및 방법들도 역시 포함된다.
The invention includes the use of the HE/HE4a markers to assess ovarian cancer in a subject. Included also are compositions and methods of using HE/HE4a marker for diagnosis, grading and staging of ovarian cancers, determining prognosis and treatment effectiveness of a subject who has been diagnosed with ovarian cancer.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLA2UXD29w3wD_YM8fT3C1Zw9HNR8HUN8fB3CVbwd1MIDXZVcPMPUnBxDXEN8vX0cwSpAkl4uJok8jCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSSeO8gIwNDCwMDQxMjY0tHY-JUAQBZOinP</recordid><startdate>20180207</startdate><enddate>20180207</enddate><creator>HELLSTROM INGEGERD</creator><creator>ROIJER EVA</creator><creator>RAYCRAFT JOHN</creator><creator>HELLSTROM KARL ERIK</creator><creator>FERMER CHRISTIAN</creator><scope>EVB</scope></search><sort><creationdate>20180207</creationdate><title>4 COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a</title><author>HELLSTROM INGEGERD ; ROIJER EVA ; RAYCRAFT JOHN ; HELLSTROM KARL ERIK ; FERMER CHRISTIAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20180014239A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HELLSTROM INGEGERD</creatorcontrib><creatorcontrib>ROIJER EVA</creatorcontrib><creatorcontrib>RAYCRAFT JOHN</creatorcontrib><creatorcontrib>HELLSTROM KARL ERIK</creatorcontrib><creatorcontrib>FERMER CHRISTIAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HELLSTROM INGEGERD</au><au>ROIJER EVA</au><au>RAYCRAFT JOHN</au><au>HELLSTROM KARL ERIK</au><au>FERMER CHRISTIAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>4 COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a</title><date>2018-02-07</date><risdate>2018</risdate><abstract>본 발명은 개체에게서 난소암을 평가하는 HE/HE4a 마커들의 용도를 포함한다. 난소암들의 진단, 등급 결정 및 단계 결정하고, 난소암으로 진단되었던 개체의 예후 및 치료 유효도를 결정하기 위해 HE/HE4a 마커를 사용하는 조성물들 및 방법들도 역시 포함된다.
The invention includes the use of the HE/HE4a markers to assess ovarian cancer in a subject. Included also are compositions and methods of using HE/HE4a marker for diagnosis, grading and staging of ovarian cancers, determining prognosis and treatment effectiveness of a subject who has been diagnosed with ovarian cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR20180014239A |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | 4 COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4a |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T03%3A01%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HELLSTROM%20INGEGERD&rft.date=2018-02-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20180014239A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |